文献速递新生儿儿童消化与营养儿童血液肿瘤与免疫

RNA测序分析识别新生儿急性肝衰竭的病因特异性转录特征

RNA-Sequencing Analysis Identifies Etiology Specific Transcriptional Signatures in Neonatal Acute Liver Failure.
PubMed 文献 · J Pediatr · 2022-10-03

本研究对比了新生儿急性肝衰竭(ALF)中妊娠同种免疫性肝病(GALD)与其他病因及无肝病新生儿的肝脏转录特征。结论为GALD存在独特上调通路及潜在疾病特异性诊断生物标志物。

要点

  • GALD上调补体激活、纤维化和器官发生通路,非GALD上调干扰素驱动免疫通路。
  • GALD中MMP7、HGF和CXCL14等基因上调,可能为候选生物标志物。

核心结论

  • GALD与非GALD病因的新生儿ALF存在显著不同的肝脏转录通路上调,并发现潜在疾病特异性诊断生物标志物。

研究设计与样本

  • 在芝加哥Ann & Robert H. Lurie儿童医院识别2010至2021年间出生30天内INR≥2的新生儿ALF及无肝病 deceased 新生儿(<30天)且有肝组织者,比较临床信息、肝组织学和RNA测序数据。

主要发现

  • RNA测序基因集富集分析显示GALD中补体激活、纤维化和器官发生通路上调。
  • 非GALD病因新生儿ALF中干扰素驱动免疫通路基因表达增加。
  • GALD中上调的个别基因包括基质金属蛋白酶7、肝细胞生长因子和趋化因子配体14。

临床怎么用

  • 新生儿ALF病因鉴别时可关注肝脏转录通路差异:GALD以补体激活和纤维化通路为特征,非GALD以干扰素免疫通路为特征。
  • MMP7、HGF和CXCL14等基因上调提示可能作为GALD诊断生物标志物,但需未来研究验证。

局限性

  • 研究为单中心回顾性设计,样本量有限。
  • 发现的生物标志物需未来研究验证以提高诊断准确性并降低GALD相关死亡率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess hepatic transcriptional signatures in infants with gestational alloimmune liver disease (GALD) compared with other etiologies of neonatal acute liver failure (ALF) and older pediatric patients with ALF. STUDY DESIGN: Neonates with ALF (international normalized ratio ≥2 within 30 days of life) and deceased neonates without liver disease (<30 days of age) with available liver tissue between 2010 and 2021 were identified at Ann & Robert H. Lurie Children's Hospital of Chicago. Clinical information, liver histology, and data from RNA-sequencing analysis was compared between neonates with GALD, non-GALD etiologies of neonatal ALF, and nondiseased neonatal liver. RESULTS: Quantification of trichrome staining showed an increase in fibrosis in patients with GALD vs those with non-GALD neonatal ALF (P = .012); however, quantification of α-cytokeratin 19-positive ductules did not differ between groups (P = .244). Gene set enrichment analysis of RNA-sequencing data identified the pathways of complement activation, fibrosis, and organogenesis to be upregulated in patients with GALD with ALF. In contrast, patients with non-GALD causes of neonatal ALF had increased gene expression for interferon-driven immune pathways. Individual genes upregulated in GALD included matrix metallopeptidase 7, hepatocyte growth factor, and chemokine ligand 14. CONCLUSIONS: We have identified distinct pathways that are significantly upregulated in patients with GALD and potential disease-specific diagnostic biomarkers. Future studies will aim to validate these findings and help identify GALD-specific diagnostic biomarkers to improve diagnostic accuracy and reduce GALD-associated patient mortality.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Saul SA, Chapin CA, Malladi P, et al. RNA-Sequencing Analysis Identifies Etiology Specific Transcriptional Signatures in Neonatal Acute Liver Failure. J Pediatr. 2022. PMID: 36195310. doi:10.1016/j.jpeds.2022.09.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。